Bifidobacterium infantis BI02
- Reduced Risk of Necrotizing Enterocolitis
- Increased Body Weight
- Reduced Intestinal Inflammation
- Reduced Intestinal Permeability
- Increased Fecal Bifidobacteria Levels
- Reduced Stool Frequency
- Improved Intestinal Barrier Function
- Reduced Pro-inflammatory Cytokine Release
- Reduced Gastrointestinal Symptoms
- Reduced Diarrhea Incidence